Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

HALOZYME THERAPEUTICS, INC. (HALO)

Income Statement Product | Geographic

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-Q10-Q10-Q10-Q10-Q10-K10-Q10-Q
Total revenues  221.0162.1209.0152.4117.3102.0115.8136.5
            Revenue growth  45.1%38.3%80.4%11.7%31.7%-16.2%77.3%147.1%
Cost of goods sold  50.135.247.333.915.921.618.623.0
Gross profit  171.0127.0161.7118.4101.480.497.2113.4
            Gross margin  77.3%78.3%77.4%77.7%86.4%78.8%84.0%83.1%
Selling, general and administrative   [+]38.937.434.557.513.813.813.212.3
Research and development  19.718.016.715.511.910.18.58.1
EBITDA   [+]115.174.3112.546.676.457.376.393.8
            EBITDA margin  52.1%45.8%53.8%30.6%65.2%56.2%65.9%68.7%
Depreciation  2.82.62.01.10.80.80.80.7
EBITA  112.371.6110.545.575.756.575.693.0
            EBITA margin  50.8%44.2%52.9%29.8%64.5%55.4%65.3%68.2%
Amortization of intangibles  17.817.827.211.4    
EBIT   [+]94.553.883.334.175.756.575.693.0
            EBIT margin  42.7%33.2%39.9%22.4%64.5%55.4%65.3%68.2%
Interest expense  4.54.57.53.11.82.11.81.8
Other income (expense), net  3.23.0-2.1-0.90.50.30.30.2
Pre-tax income  93.252.273.730.074.454.874.191.5
Income taxes  18.412.612.17.314.3-12.0-142.50.1
            Tax rate  19.8%24.2%16.4%24.4%19.2%  0.1%
Net income  74.839.661.622.760.166.8216.691.5
            Net margin  33.8%24.4%29.5%14.9%51.3%65.5%187.0%67.0%
   
Basic EPS   [+]$0.57$0.29$0.45$0.16$0.44$0.47$1.53$0.64
Diluted EPS   [+]$0.56$0.29$0.44$0.16$0.43$0.45$1.48$0.62
   
Shares outstanding (basic)   [+]131.7135.0136.5137.9137.7140.6142.0142.5
Shares outstanding (diluted)   [+]133.5137.9139.4142.2141.3146.8146.7147.6
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy